Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > No trades

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Jun 02, 2021 6:19pm

140 Views

Post# 33315790

RE:RE:RE:RE:RE:No trades

It's always darkest before the Great Rebrand?? This is really testing my faith, so collectively do we have it right, does Mr. Market have it right or is this simply an IR failure?

stockman75 wrote: I sure hope you are right but I have hard time finding that optimism.

SPCEO1 wrote: There is still time for TH to avoid that fate. But there is no denying the week is off to a slow start. Hopefully, what we are seeing is the calm before they unleash an IR storm and that their time is being consumed by putting the finishing touches on the Great Rebranding. Maybe we can move on from the OO to the GR.

stockman75 wrote: I am going to go out on a strong limb and guess we get another D to F report this week!